UnitedHealth Group Just 52-Week High: Is It Too Late to Buy?
UnitedHealth Group just 52-week highs spark questions about sustainability. This guide breaks down what's driving the...
Evaluate historical worst drawdowns for index funds and translate insights into practical risk controls and withdrawal planning.
14,434 articlesUnitedHealth Group just 52-week highs spark questions about sustainability. This guide breaks down what's driving the...
May data showed a resilient job market amid softer growth signals, fueling fears that economic news piling recession ...
A shortened trading week features June triple witching and SpaceX contract launches, setting the stage for heightened...
Oil prices moved in a narrow range as investors weigh a potential U.S.-Iran deal that could reopen the Strait of Horm...
Investors confront a major test coming stock environment as the Fed signals it won’t step in to cushion losses. Morga...
A new five-pillar framework unveiled by a top U.S. official signals a hard turn toward reshoring, tougher trade terms...
A flurry of news sent Kymera Therapeutics stock popping this week. From trial milestones to new price targets and ins...
A single metric helps explain the uneasy mood among Americans: the declining share of income going to workers as prof...
The Dow Jones Industrial Average surged to a new record as investors rotated into value stocks while technology wobbl...
As 2026 unfolds, investors face a clear choice between Lilly's growth engine in big markets and Teva's value-forward ...
Broadcom’s AI chip revenue jumped in Q2 2026, with guidance hinting at even stronger growth ahead. This article break...
Analysts are revising upward expectations for the Q2 earnings season, driven by energy and technology strength, a rar...